TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-018-0351-2

PubMed Identifier: 30635634

Publication URI: http://europepmc.org/abstract/MED/30635634

Type: Journal Article/Review

Volume: 33

Parent Publication: Leukemia

Issue: 7

ISSN: 0887-6924